Crimson Life Sciences

11 articles about Crimson Life Sciences

• Crimson Life Sciences Offers Cost-Saving Technology Solution for Chinese Regulation 276

  11/5/2012

• First Patent for Translation Risk Management Awarded to Crimson Life Sciences

  4/18/2012

• Crimson Life Sciences Release: In-Vitro Diagnostics (IVD) Manufacturers at Risk for Device Reclassification

  3/20/2012

• Crimson Life Sciences Release: Expert Opinion Webcast Reveals $400 Million Potential Savings for Medical Device Industry

  2/14/2012

• Crimson Life Sciences Release: U.S. Medical Device “Total Cost of Content” Estimated at over $1 Billion

  10/18/2011

• Crimson Life Sciences Launches Japan Digest to Provide Market Insight for U.S. Medical Device Manufacturers

  8/23/2011

• Crimson Life Sciences Solves Japanese Translation Dilemma for U.S. Medical Device Manufacturers

  5/2/2011

• Crimson Life Sciences Release: Medical Device Risk Management Milestone: Industry's First 14971-Registered System Achieves Recertification

  7/15/2010

• Crimson Life Sciences Provides Online Resource for Medical Device Firms Seeking Reimbursement Guidance

  6/22/2010

• Crimson Life Sciences Introduces "Expert Opinion" Educational Webinar Series

  5/27/2009

• Crimson Life Sciences Release: ISO 14971-Certified Risk Management System Yields First Labeling Translation Patent

  2/19/2008